← All organizations
Highest phase reached
Phase 4
First clinical trial
Apr 16, 2013Last known activity
Apr 30, 2020
Timeline
2010s
- Apr 16, 2013
Mochida Pharmaceutical Company, Ltd.— Founded
Drugs by trial phase (9 distinct, 17 trials)
Phase 4 (1 own, 0 via acquisition)
Phase 3 (6 own, 0 via acquisition)
Indications
Studied for
- Angina Pectoris
- Angina, Unstable
- Arthritis
- Arthritis, Rheumatoid
- Death
- Death, Sudden, Cardiac
- Depression
- Depressive Disorder
- Fatty Liver
- Gout
- Hepatic Insufficiency
- Hypertriglyceridemia
- Hyperuricemia
- Infarction
- Liver Failure
- Major Depressive Disorder
- Myocardial Infarction
- Non-alcoholic Fatty Liver Disease
- Peripheral Arterial Disease
Recent trials (26)
- NCT04345471Lead sponsorPhase 3Apr 30, 2020
- NCT04345471Study directorPhase 3Apr 30, 2020
- NCT04221217Study directorPhase 3Feb 1, 2020
- NCT04221217Lead sponsorPhase 3Feb 1, 2020
- NCT04239950Lead sponsorPhase 3Jan 20, 2020
- NCT04239950Study directorPhase 3Jan 20, 2020
- NCT03693131Lead sponsorPhase 3Oct 31, 2018
- NCT03693131Study directorPhase 3Oct 31, 2018
- NCT03372200Lead sponsorPhase 3Jan 9, 2018
- NCT03372200Study directorPhase 3Jan 9, 2018
- NCT03375632Lead sponsorPhase 1Jan 4, 2018
- NCT03375632Study directorPhase 1Jan 4, 2018
- NCT03350373Lead sponsorPhase 1Nov 6, 2017
- NCT03350373Study directorPhase 1Nov 6, 2017
- NCT03350386Lead sponsorPhase 1Nov 2, 2017
Details
- Founded
- Tokyo, JP Apr 16, 2013
- Last known activity
- Apr 30, 2020